- Home
- ESE vs LNTH Comparison
ESE vs LNTH Comparison
Compare ESE & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESE
- LNTH
- Stock Information
- Founded
- ESE 1990
- LNTH 1956
- Country
- ESE United States
- LNTH United States
- Employees
- ESE N/A
- LNTH N/A
- Industry
- ESE Telecommunications Equipment
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ESE Telecommunications
- LNTH Health Care
- Exchange
- ESE Nasdaq
- LNTH Nasdaq
- Market Cap
- ESE 4.9B
- LNTH 5.7B
- IPO Year
- ESE N/A
- LNTH 2015
- Fundamental
- Price
- ESE $191.38
- LNTH $81.26
- Analyst Decision
- ESE Strong Buy
- LNTH Strong Buy
- Analyst Count
- ESE 2
- LNTH 5
- Target Price
- ESE $187.50
- LNTH $131.20
- AVG Volume (30 Days)
- ESE 220.0K
- LNTH 903.4K
- Earning Date
- ESE 08-06-2025
- LNTH 07-30-2025
- Dividend Yield
- ESE 0.17%
- LNTH N/A
- EPS Growth
- ESE 19.62
- LNTH N/A
- EPS
- ESE 4.56
- LNTH 3.53
- Revenue
- ESE $1,071,861,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- ESE $17.26
- LNTH $4.63
- Revenue Next Year
- ESE $14.04
- LNTH $9.35
- P/E Ratio
- ESE $42.23
- LNTH $23.01
- Revenue Growth
- ESE 8.40
- LNTH 12.53
- 52 Week Low
- ESE $108.70
- LNTH $73.11
- 52 Week High
- ESE $196.13
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- ESE 56.11
- LNTH 49.75
- Support Level
- ESE $184.54
- LNTH $78.74
- Resistance Level
- ESE $194.65
- LNTH $85.31
- Average True Range (ATR)
- ESE 4.08
- LNTH 2.31
- MACD
- ESE -0.47
- LNTH 0.36
- Stochastic Oscillator
- ESE 59.02
- LNTH 41.30
About ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG), and Test. The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.